Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Consolidated Net Income (2016 - 2025)

Marimed has reported Consolidated Net Income over the past 15 years, most recently at -$4.6 million for Q4 2025.

  • Quarterly Consolidated Net Income rose 43.84% to -$4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$14.3 million through Dec 2025, down 17.13% year-over-year, with the annual reading at -$14.5 million for FY2025, 16.3% down from the prior year.
  • Consolidated Net Income was -$4.6 million for Q4 2025 at Marimed, down from -$2.9 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $7.6 million in Q2 2021 and troughed at -$10.1 million in Q4 2023.
  • The 5-year median for Consolidated Net Income is -$1.1 million (2024), against an average of -$1.1 million.
  • Year-over-year, Consolidated Net Income surged 764.98% in 2021 and then tumbled 319.5% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at -$6.4 million in 2021, then surged by 174.23% to $4.7 million in 2022, then crashed by 313.27% to -$10.1 million in 2023, then increased by 18.4% to -$8.3 million in 2024, then soared by 43.84% to -$4.6 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Consolidated Net Income are -$4.6 million (Q4 2025), -$2.9 million (Q3 2025), and -$1.3 million (Q2 2025).